Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Contraception ; 102(2): 70-82, 2020 08.
Article in English | MEDLINE | ID: mdl-32304766

ABSTRACT

Everyone of reproductive potential, no matter sex or gender, may have contraceptive needs. However, with no professional society guidelines and scant data on contraceptive use for transgender and gender-diverse (TGD) populations, clinicians' abilities to counsel patients on use, safety, side effects, and efficacy is severely limited. We know very little about how estrogen- and progestin-containing contraceptive methods interact with gender-affirming testosterone therapy. Consequently, providers must extrapolate from data on use of hormonal contraceptive methods in presumed cisgender women and rely on clinical expertise. Based on available literature and expert opinion, there are important considerations for each method that can help guide contraceptive counseling with TGD patients. Specific considerations include differential experience of side-effects in TGD patients, barriers to access, and potential misconceptions regarding menstruation and reproductive capacity. When counseling a TGD person about their contraception options, providers should engage in shared decision-making, acknowledging the spectrum of identities and experiences within these communities. In order to support gender-affirming patient-centered care, providers should also create a space that is welcoming, use language that promotes inclusivity, and perform physical exams that consider the potential physical and emotional discomforts specific to these patients. Given the lack of population-specific data and guidelines, we encourage providers to integrate what is known about contraceptive use in cisgender women with the unique needs of TGD persons to apply a shared decision-making contraceptive counseling approach with members of these communities.


Subject(s)
Family Planning Services , Transgender Persons , Contraception , Contraceptive Agents , Counseling , Female , Humans , Infant, Newborn
2.
Obstet Gynecol ; 132(1): 217, 2018 07.
Article in English | MEDLINE | ID: mdl-29939920
3.
Obstet Gynecol ; 131(4): 632-634, 2018 04.
Article in English | MEDLINE | ID: mdl-29528927

ABSTRACT

A 30-year-old nulligravid woman is referred to you for heavy menstrual cycles. Although her menstrual cycles were previously light, she was recently diagnosed with an unprovoked lower extremity venous thromboembolism and is taking anticoagulation therapy after a negative thrombophilia workup. She wants help with her vaginal bleeding and desires contraception.


Subject(s)
Anticoagulants/therapeutic use , Contraception/methods , Menorrhagia/chemically induced , Progestins/therapeutic use , Venous Thromboembolism/drug therapy , Administration, Oral , Adult , Female , Humans , Menorrhagia/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...